FTSE 100
8.798,91
PKT
+63,31
PKT
+0,72
%
Werbung
Analysen zu FTSE 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
27.04.16 | HSBC Neutral | Goldman Sachs Group Inc. | |
27.04.16 | AstraZeneca buy | UBS AG | |
27.04.16 | BP buy | UBS AG | |
27.04.16 | BAT buy | UBS AG | |
27.04.16 | BAT buy | Société Générale Group S.A. (SG) | |
27.04.16 | BP buy | Société Générale Group S.A. (SG) | |
26.04.16 | GSK neutral | Bernstein Research | |
26.04.16 | AstraZeneca neutral | Bernstein Research | |
25.04.16 | Imperial Brands buy | Goldman Sachs Group Inc. | |
25.04.16 | Vodafone Group buy | Citigroup Corp. | |
25.04.16 | GSK buy | Citigroup Corp. | |
25.04.16 | Vodafone Group buy | UBS AG | |
25.04.16 | International Consolidated Airlines buy | UBS AG | |
25.04.16 | Lloyds Banking Group buy | HSBC | |
25.04.16 | GSK Neutral | JP Morgan Chase & Co. | |
25.04.16 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
22.04.16 | Reckitt Benckiser buy | Deutsche Bank AG | |
22.04.16 | Unilever buy | Deutsche Bank AG | |
22.04.16 | Barclays Hold | Deutsche Bank AG | |
22.04.16 | BAT buy | Jefferies & Company Inc. | |
21.04.16 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
21.04.16 | BP buy | HSBC | |
21.04.16 | Shell (ex Royal Dutch Shell) buy | HSBC | |
21.04.16 | GSK Neutral | BNP PARIBAS | |
21.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
21.04.16 | GSK Neutral | UBS AG | |
21.04.16 | Barclays buy | UBS AG | |
20.04.16 | GSK Equal-Weight | Morgan Stanley | |
20.04.16 | Vodafone Group buy | Merrill Lynch & Co., Inc. | |
20.04.16 | HSBC buy | Citigroup Corp. | |
20.04.16 | Rio Tinto buy | UBS AG | |
20.04.16 | Rio Tinto overweight | JP Morgan Chase & Co. | |
20.04.16 | BT Group Hold | Jefferies & Company Inc. | |
19.04.16 | Rio Tinto Verkaufen | Independent Research GmbH | |
19.04.16 | Rio Tinto Equal-Weight | Morgan Stanley | |
19.04.16 | Reckitt Benckiser kaufen | BNP PARIBAS | |
19.04.16 | National Grid Underperform | BNP PARIBAS | |
19.04.16 | National Grid Underperform | BNP PARIBAS | |
19.04.16 | Reckitt Benckiser overweight | JP Morgan Chase & Co. | |
19.04.16 | Reckitt Benckiser buy | HSBC |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.